TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group

Affiliations

• ¹ Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany.
• ² German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
• ³ Department of Neurosurgery & Division of Neuro-Oncology, University of San Francisco, San Francisco, California, USA.
• ⁴ Department of Neurosurgery, McGovern Medical School at UT Health Houston, Houston, Texas, USA.
• ⁵ Department of Neurosurgery, University of Freiburg, Freiburg, Germany.
• ⁶ Department of Neurosurgery, University of Cologne, Cologne, Germany.
• ⁷ Division for Neuro-Oncology, Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
• ⁸ Division of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy.
• ⁹ Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
• ¹⁰ Department of NeuroOncology, Moffitt Cancer Center, Tampa, Florida, USA.
• ¹¹ Division of Neurology, Castelfranco Veneto and Treviso Hospital, Treviso, Italy.
• ¹² Department of Stereotactic and Functional Neurosurgery, Centre for Neurosurgery, University Hospital Cologne, Cologne, Germany.
• ¹³ Klinikum Fulda, Academic Hospital of Marburg University, Fulda, Germany.
• ¹⁴ Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
• ¹⁵ Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.